查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2019788

血液輸注診斷市場規模、佔有率、成長及全球產業分析：按類型和應用、區域洞察及2026-2034年預測

Blood Transfusion Diagnostics Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 190 Pages | 商品交期: 請詢問到貨日

價格

血液輸注診斷市場的成長要素

受對更安全輸血流程的需求不斷成長以及血液相關疾病發病率上升的推動，全球輸血診斷市場正經歷強勁成長。預計該市場規模將在2025年達到57億美元，2026年達到61.2億美元，並在2034年進一步擴大至112.5億美元。此穩定成長在預測期內的複合年成長率（CAGR）為7.90%。 2025年，北美將以39.71%的市佔率引領市場，這得益於其先進的醫療基礎設施和高度的血液安全意識。

輸血診斷是指輸血前對血液樣本進行的一系列檢測，以確認供血者和受血者的血型是否相容，並預防感染疾病的傳播。這些檢測包括血型鑑定、抗體篩檢和輸血傳染性行為感染（TTI）的檢測。由於輸血療法在外科手術、創傷治療和慢性病管理中發揮著至關重要的作用，因此，準確的診斷程序在全球範圍內的重要性日益凸顯。

市場趨勢

推動市場發展的關鍵趨勢之一是轉型為自動化和分子診斷平台。自動化顯著提高了血液檢測流程的準確性、速度和效率。核酸檢測 (NAT) 和 DG 凝膠系統等技術正日益廣泛地應用，以最大限度地減少人為誤差並提高可靠性。這些創新使檢查室和血庫能夠簡化操作流程、提高病患安全，並最終推動市場成長。

市場成長要素

對血液及血液成分日益成長的需求是市場擴張的主要驅動力。貧血、癌症和腎臟病等慢性疾病的盛行率不斷上升，顯著增加了定期輸血的需求。此外，外科手術、創傷病例和分娩併發症的增加也進一步推動了血液診斷的需求。

另一個重要的成長要素是人們對血液安全的日益重視。各國政府、醫療機構和非政府組織都在積極推廣安全的捐血規範和篩檢程序。這促使醫院、檢查室和血庫採用先進的診斷工具，進而支持市場成長。

抑制因子

儘管市場成長前景強勁，但也面臨一些挑戰。診斷設備和檢測套組的高成本是一大障礙，尤其是在發展中地區。此外，醫療基礎設施和專業人員的匱乏也阻礙了先進診斷技術的應用。這些因素限制了醫療投資相對較低的新興國家的市場成長。

細分分析

按產品類型分類，試劑和試劑盒由於在血液篩檢和血型鑑定程序中反覆使用而佔市場主導地位，預計到 2026 年將佔 79.46% 的市場佔有率。設備部分由於成本高、使用壽命長，市佔率較小。

按應用領域分類，預計到2026年，血液篩檢領域將以69.06%的市場佔有率引領市場，這主要得益於捐血中感染疾病檢測需求的不斷成長。血型鑑定業務也在穩定成長，這主要受血型相容性檢測需求增加的推動。

就最終用戶而言，預計到 2026 年，全球處理大量血液檢測的獨立實驗室和血庫將主導市場，佔總市場佔有率的 60.89%。

區域趨勢

北美仍然是一個主要地區，預計到 2025 年市場規模將達到 22.6 億美元，到 2026 年將達到 24.2 億美元。這得益於其健全的醫療保健系統和較高的輸血率。

在先進的診斷技術和監管支援的推動下，預計到 2025 年歐洲市場規模將達到 16.1 億美元，到 2026 年將成長至 17.3 億美元。

預計亞太地區在 2025 年將達到 13.1 億美元，在 2026 年將達到 14.3 億美元，成長速度最快，這主要得益於人口成長、醫療保健投資增加和宣傳活動的開展。

拉丁美洲、中東和非洲地區正經歷溫和成長，這得益於醫療保健服務的改善和尚未開發的市場機會。

目錄

第1章：引言

第2章摘要整理

第3章 市場動態

  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場趨勢

第4章：主要考慮因素

  • 2025年主要國家捐血統計數據
  • 新冠疫情對市場的影響
  • 2025年主要地區和國家主要出血性疾病盛行率
  • 中國捐血血型分佈
  • 印度和美國人口血型分佈情況
  • 2025年輸血統計數據
  • 產業重大發展動態－合併、收購、合作等。

第5章：2021-2034年全球輸血診斷市場分析、洞察與預測

  • 市場分析、洞察與預測：按產品分類。
    • 裝置
    • 試劑和試劑盒
  • 市場分析、洞察與預測：按應用領域分類
    • 血液篩檢
    • 血型測定
  • 市場分析、洞察與預測：按最終用戶分類
    • 醫院檢查室
    • 獨立檢測實驗室和血庫
  • 市場分析、洞察與預測：按地區分類
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲

第6章：北美輸血診斷市場分析、洞察與預測（2021-2034年）

  • 國家
    • 美國
    • 加拿大

第7章：歐洲輸血診斷市場分析、洞察與預測（2021-2034年）

  • 國家
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 義大利
    • 斯堪地那維亞
    • 其他歐洲國家

第8章：亞太地區輸血診斷市場分析、洞察與預測（2021-2034年）

  • 國家
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 東南亞
    • 其他亞太國家

第9章：拉丁美洲輸血診斷市場分析、洞察與預測（2021-2034年）

  • 國家
    • 巴西
    • 墨西哥
    • 其他拉丁美洲國家

第10章：中東和非洲輸血診斷市場分析、洞察與預測（2021-2034年）

  • 國家
    • 海灣合作理事會國家
    • 南非
    • 其他中東和非洲國家

第11章 競爭分析

  • 全球市佔率分析（2025 年）
  • 公司簡介
    • Abbott
    • F. Hoffmann-La Roche AG
    • Grifols, SA
    • Immucor, Inc.
    • Bio-Rad Laboratories, Inc.
    • Ortho Clinical Diagnostics
    • QUOTIENT
    • Merck KGaA
Product Code: FBI100596

Growth Factors of blood transfusion diagnostics Market

The global blood transfusion diagnostics market is witnessing strong growth due to the rising demand for safe blood transfusion procedures and increasing prevalence of blood-related disorders. The market was valued at USD 5.70 billion in 2025 and is projected to reach USD 6.12 billion in 2026, further expanding to USD 11.25 billion by 2034. This steady growth reflects a CAGR of 7.90% during the forecast period. In 2025, North America dominated the market with a 39.71% share, driven by advanced healthcare infrastructure and high awareness of blood safety.

Blood transfusion diagnostics refers to a range of tests conducted on blood samples before transfusion to ensure compatibility between donor and recipient and to prevent the transmission of infectious diseases. These tests include blood grouping, antibody screening, and detection of transfusion-transmissible infections (TTIs). As transfusion therapy plays a vital role in surgeries, trauma care, and chronic disease management, the importance of accurate diagnostic procedures continues to grow globally.

Market Trends

One of the major trends shaping the market is the shift toward automated and molecular diagnostic platforms. Automation has significantly improved the accuracy, speed, and efficiency of blood testing processes. Technologies such as nucleic acid testing (NAT) and DG gel systems are increasingly being adopted to minimize human error and enhance reliability. These innovations allow laboratories and blood banks to streamline operations and improve patient safety, thereby boosting market growth.

Market Growth Drivers

The increasing demand for blood and blood components is a key factor driving market expansion. The rising prevalence of chronic diseases such as anemia, cancer, and kidney disorders has significantly increased the need for regular blood transfusions. Additionally, the growing number of surgical procedures, trauma cases, and childbirth-related complications further fuels the demand for blood diagnostics.

Another important growth factor is the rising awareness regarding blood safety. Governments, healthcare organizations, and NGOs are actively promoting safe blood donation practices and screening protocols. This has led to increased adoption of advanced diagnostic tools across hospitals, laboratories, and blood banks, thereby supporting market growth.

Restraining Factors

Despite strong growth prospects, the market faces certain challenges. The high cost of diagnostic instruments and testing kits is a major barrier, especially in developing regions. Additionally, limited healthcare infrastructure and a shortage of skilled professionals hinder the adoption of advanced diagnostic technologies. These factors restrict market growth in emerging economies where healthcare investments are comparatively low.

Segmentation Analysis

By product type, the reagents and kits segment dominates the market, accounting for 79.46% share in 2026, due to their recurring use in blood screening and typing procedures. The instruments segment holds a smaller share due to higher costs and longer lifecycle.

Based on application, the blood screening segment leads the market with a 69.06% share in 2026, driven by the increasing need to detect infectious diseases in donated blood. Blood group typing is also growing steadily due to rising demand for compatibility testing.

By end-user, independent laboratories and blood banks dominate with a 60.89% share in 2026, as they handle a large volume of blood testing procedures globally.

Regional Insights

North America remains the leading region, valued at USD 2.26 billion in 2025 and projected to reach USD 2.42 billion in 2026, supported by strong healthcare systems and high transfusion rates.

Europe held USD 1.61 billion in 2025, growing to USD 1.73 billion in 2026, driven by advanced diagnostic technologies and regulatory support.

Asia Pacific accounted for USD 1.31 billion in 2025 and is expected to reach USD 1.43 billion in 2026, witnessing the fastest growth due to rising population, increasing healthcare investments, and awareness programs.

Latin America and the Middle East & Africa show moderate growth, supported by improving healthcare access and untapped market opportunities.

Competitive Landscape

The market is highly competitive with key players such as Immucor, Inc., Grifols, S.A., Ortho Clinical Diagnostics, Abbott Laboratories, and F. Hoffmann-La Roche Ltd. These companies focus on product innovation, strong distribution networks, and strategic collaborations to strengthen their market presence.

Conclusion

In conclusion, the blood transfusion diagnostics market is set for substantial growth from USD 5.70 billion in 2025 to USD 11.25 billion by 2034, driven by rising healthcare needs, technological advancements, and increasing awareness of blood safety. While high costs and infrastructure limitations pose challenges, ongoing innovations and global health initiatives are expected to overcome these barriers. The market will continue to play a critical role in ensuring safe and efficient transfusion practices worldwide.

Growth Rate CAGR of 7.90% from 2026-2034

Segmentation By Product

  • Instruments
  • Kits & Reagents

By Application

  • Blood Screening
  • Blood Group Typing

By End-user

  • Hospital-based Laboratories
  • Independent Laboratories & Blood Banks

By Geography

  • North America (By Product, By Application, By End-user, and By Country)
    • U.S. (By Application)
    • Canada (By Application)
  • Europe (By Product, By Application, By End-user, and By Country/ Sub-region)
    • U.K. (By Application)
    • Germany (By Application)
    • France (By Application)
    • Italy (By Application)
    • Spain (By Application)
    • Scandinavia (By Application)
    • Rest of Europe (By Application)
  • Asia Pacific (By Product, By Application, By End-user, and By Country/ Sub-region)
    • China (By Application)
    • Japan (By Application)
    • India (By Application)
    • Australia (By Application)
    • Southeast Asia (By Application)
    • Rest of Asia Pacific (By Application)
  • Latin America (By Product, By Application, By End-user, and By Country/ Sub-region)
    • Brazil (By Application)
    • Mexico (By Application)
    • Rest of Latin America (By Application)
  • Middle East & Africa (By Product, By Application, By End-user, and By Country/ Sub-region)
    • GCC (By Application)
    • South Africa (By Application)
  • Rest of the Middle East & Africa (By Application)

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Blood Donations Statistics, By Key Countries, 2025
  • 4.2. Impact of COVID-19 on the Market
  • 4.3. Prevalence of Key Bleeding Disorders, Key Regions/ Country, 2025
  • 4.4. Blood Group Distribution Among Blood Donors in China
  • 4.5. Distribution of Blood Group Type Among Indian & the U.S. Population
  • 4.6. Blood Transfusion Statistics, 2025
  • 4.7. Key Industry Developments- Mergers, Acquisitions, Partnerships, etc.

5. Global Blood Transfusion Diagnostics Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Product
    • 5.1.1. Instruments
    • 5.1.2. Reagents & Kits
  • 5.2. Market Analysis, Insights and Forecast - By Application
    • 5.2.1. Blood Screening
    • 5.2.2. Blood Group Typing
  • 5.3. Market Analysis, Insights and Forecast - By End-user
    • 5.3.1. Hospital-based Laboratories
    • 5.3.2. Independent Laboratories & Blood Banks
  • 5.4. Market Analysis, Insights and Forecast - By Region
    • 5.4.1. North America
    • 5.4.2. Europe
    • 5.4.3. Asia Pacific
    • 5.4.4. Latin America
    • 5.4.5. Middle East & Africa

6. North America Blood Transfusion Diagnostics Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Product
    • 6.1.1. Instruments
    • 6.1.2. Reagents & Kits
  • 6.2. Market Analysis, Insights and Forecast - By Application
    • 6.2.1. Blood Screening
    • 6.2.2. Blood Group Typing
  • 6.3. Market Analysis, Insights and Forecast - By End-user
    • 6.3.1. Hospital-based Laboratories
    • 6.3.2. Independent Laboratories & Blood Banks
  • 6.4. Market Analysis, Insights and Forecast - By Country
    • 6.4.1. U.S.
      • 6.4.1.1. By Application
    • 6.4.2. Canada
      • 6.4.2.1. By Application

7. Europe Blood Transfusion Diagnostics Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Product
    • 7.1.1. Instruments
    • 7.1.2. Reagents & Kits
  • 7.2. Market Analysis, Insights and Forecast - By Application
    • 7.2.1. Blood Screening
    • 7.2.2. Blood Group Typing
  • 7.3. Market Analysis, Insights and Forecast - By End-user
    • 7.3.1. Hospital-based Laboratories
    • 7.3.2. Independent Laboratories & Blood Banks
  • 7.4. Market Analysis, Insights and Forecast - By Country/ Sub-region
    • 7.4.1. U.K.
      • 7.4.1.1. By Application
    • 7.4.2. Germany
      • 7.4.2.1. By Application
    • 7.4.3. France
      • 7.4.3.1. By Application
    • 7.4.4. Spain
      • 7.4.4.1. By Application
    • 7.4.5. Italy
      • 7.4.5.1. By Application
    • 7.4.6. Scandinavia
      • 7.4.6.1. By Application
    • 7.4.7. Rest of Europe
      • 7.4.7.1. By Application

8. Asia Pacific Blood Transfusion Diagnostics Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Product
    • 8.1.1. Instruments
    • 8.1.2. Reagents & Kits
  • 8.2. Market Analysis, Insights and Forecast - By Application
    • 8.2.1. Blood Screening
    • 8.2.2. Blood Group Typing
  • 8.3. Market Analysis, Insights and Forecast - By End-user
    • 8.3.1. Hospital-based Laboratories
    • 8.3.2. Independent Laboratories & Blood Banks
  • 8.4. Market Analysis, Insights and Forecast - By Country/ Sub-region
    • 8.4.1. Japan
      • 8.4.1.1. By Application
    • 8.4.2. China
      • 8.4.2.1. By Application
    • 8.4.3. India
      • 8.4.3.1. By Application
    • 8.4.4. Australia
      • 8.4.4.1. By Application
    • 8.4.5. Southeast Asia
      • 8.4.5.1. By Application
    • 8.4.6. Rest of Asia Pacific
      • 8.4.6.1. By Application

9. Latin America Blood Transfusion Diagnostics Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Product
    • 9.1.1. Instruments
    • 9.1.2. Reagents & Kits
  • 9.2. Market Analysis, Insights and Forecast - By Application
    • 9.2.1. Blood Screening
    • 9.2.2. Blood Group Typing
  • 9.3. Market Analysis, Insights and Forecast - By End-user
    • 9.3.1. Hospital-based Laboratories
    • 9.3.2. Independent Laboratories & Blood Banks
  • 9.4. Market Analysis, Insights and Forecast - By Country/ Sub-region
    • 9.4.1. Brazil
      • 9.4.1.1. By Application
    • 9.4.2. Mexico
      • 9.4.2.1. By Application
    • 9.4.3. Rest of Latin America
      • 9.4.3.1. By Application

10. Middle East & Africa Blood Transfusion Diagnostics Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Product
    • 10.1.1. Instruments
    • 10.1.2. Reagents & Kits
  • 10.2. Market Analysis, Insights and Forecast - By Application
    • 10.2.1. Blood Screening
    • 10.2.2. Blood Group Typing
  • 10.3. Market Analysis, Insights and Forecast - By End-user
    • 10.3.1. Hospital-based Laboratories
    • 10.3.2. Independent Laboratories & Blood Banks
  • 10.4. Market Analysis, Insights and Forecast - By Country/ Sub-region
    • 10.4.1. GCC Countries
      • 10.4.1.1. By Application
    • 10.4.2. South Africa
      • 10.4.2.1. By Application
    • 10.4.3. Rest of Middle East & Africa
      • 10.4.3.1. By Application

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2025)
  • 11.2. Company Profiles
    • 11.2.1. Abbott
      • 11.2.1.1. Overview
      • 11.2.1.2. Products & Services
      • 11.2.1.3. SWOT Analysis
      • 11.2.1.4. Recent Developments
      • 11.2.1.5. Strategies
      • 11.2.1.6. Financials (Based on Availability)
    • 11.2.2. F. Hoffmann-La Roche AG
      • 11.2.2.1. Overview
      • 11.2.2.2. Products & Services
      • 11.2.2.3. SWOT Analysis
      • 11.2.2.4. Recent Developments
      • 11.2.2.5. Strategies
      • 11.2.2.6. Financials (Based on Availability)
    • 11.2.3. Grifols, S.A.
      • 11.2.3.1. Overview
      • 11.2.3.2. Products & Services
      • 11.2.3.3. SWOT Analysis
      • 11.2.3.4. Recent Developments
      • 11.2.3.5. Strategies
      • 11.2.3.6. Financials (Based on Availability)
    • 11.2.4. Immucor, Inc.
      • 11.2.4.1. Overview
      • 11.2.4.2. Products & Services
      • 11.2.4.3. SWOT Analysis
      • 11.2.4.4. Recent Developments
      • 11.2.4.5. Strategies
      • 11.2.4.6. Financials (Based on Availability)
    • 11.2.5. Bio-Rad Laboratories, Inc.
      • 11.2.5.1. Overview
      • 11.2.5.2. Products & Services
      • 11.2.5.3. SWOT Analysis
      • 11.2.5.4. Recent Developments
      • 11.2.5.5. Strategies
      • 11.2.5.6. Financials (Based on Availability)
    • 11.2.6. Ortho Clinical Diagnostics
      • 11.2.6.1. Overview
      • 11.2.6.2. Products & Services
      • 11.2.6.3. SWOT Analysis
      • 11.2.6.4. Recent Developments
      • 11.2.6.5. Strategies
      • 11.2.6.6. Financials (Based on Availability)
    • 11.2.7. QUOTIENT
      • 11.2.7.1. Overview
      • 11.2.7.2. Products & Services
      • 11.2.7.3. SWOT Analysis
      • 11.2.7.4. Recent Developments
      • 11.2.7.5. Strategies
      • 11.2.7.6. Financials (Based on Availability)
    • 11.2.8. Merck KGaA
      • 11.2.8.1. Overview
      • 11.2.8.2. Products & Services
      • 11.2.8.3. SWOT Analysis
      • 11.2.8.4. Recent Developments
      • 11.2.8.5. Strategies
      • 11.2.8.6. Financials (Based on Availability)

List of Tables

  • Table 1: Global Blood Transfusion Diagnostics Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 2: Global Blood Transfusion Diagnostics Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 3: Global Blood Transfusion Diagnostics Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 4: Global Blood Transfusion Diagnostics Market Revenue (USD billion) Forecast, by Region, 2021-2034
  • Table 5: North America Blood Transfusion Diagnostics Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 6: North America Blood Transfusion Diagnostics Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 7: North America Blood Transfusion Diagnostics Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 8: North America Blood Transfusion Diagnostics Market Revenue (USD billion) Forecast, By Country, 2021-2034
  • Table 9: U.S. Blood Transfusion Diagnostics Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 10: Canada Blood Transfusion Diagnostics Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 11: Europe Blood Transfusion Diagnostics Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 12: Europe Blood Transfusion Diagnostics Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 13: Europe Blood Transfusion Diagnostics Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 14: Europe Blood Transfusion Diagnostics Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 15: U.K. Blood Transfusion Diagnostics Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 16: Germany Blood Transfusion Diagnostics Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 17: France Blood Transfusion Diagnostics Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 18: Italy Blood Transfusion Diagnostics Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 19: Spain Blood Transfusion Diagnostics Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 20: Scandinavia Blood Transfusion Diagnostics Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 21: Rest of Europe Blood Transfusion Diagnostics Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 22: Asia Pacific Blood Transfusion Diagnostics Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 23: Asia Pacific Blood Transfusion Diagnostics Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 24: Asia Pacific Blood Transfusion Diagnostics Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 25: Asia Pacific Blood Transfusion Diagnostics Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 26: Japan Blood Transfusion Diagnostics Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 27: China Blood Transfusion Diagnostics Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 28: India Blood Transfusion Diagnostics Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 29: Australia Blood Transfusion Diagnostics Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 30: Rest of Asia Pacific Blood Transfusion Diagnostics Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 31: Latin America Blood Transfusion Diagnostics Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 32: Latin America Blood Transfusion Diagnostics Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 33: Latin America Blood Transfusion Diagnostics Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 34: Latin America Blood Transfusion Diagnostics Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 35: Brazil Blood Transfusion Diagnostics Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 36: Mexico Blood Transfusion Diagnostics Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 37: Rest of Latin America Blood Transfusion Diagnostics Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 38: Middle East & Africa Blood Transfusion Diagnostics Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 39: Middle East & Africa Blood Transfusion Diagnostics Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 40: Middle East & Africa Blood Transfusion Diagnostics Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 41: Middle East & Africa Blood Transfusion Diagnostics Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 42: GCC Blood Transfusion Diagnostics Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 43: South Africa Blood Transfusion Diagnostics Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 44: Rest of Middle East & Africa Blood Transfusion Diagnostics Market Revenue (USD billion) Forecast, By Application, 2021-2034

List of Figures

  • Figure 1: Global Blood Transfusion Diagnostics Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034
  • Figure 2: Global Blood Transfusion Diagnostics Market Value Share (%), by Product, 2025 & 2034
  • Figure 3: Global Blood Transfusion Diagnostics Market Value Share (%), by Application, 2025 & 2034
  • Figure 4: Global Blood Transfusion Diagnostics Market Value Share (%), by End-user, 2025 & 2034
  • Figure 5: Global Blood Transfusion Diagnostics Market Value (USD billion), by Region, 2025 & 2034
  • Figure 6: North America Blood Transfusion Diagnostics Market Value (USD billion), by Product, 2025 & 2034
  • Figure 7: North America Blood Transfusion Diagnostics Market Value Share (%), by Product, 2025
  • Figure 8: North America Blood Transfusion Diagnostics Market Value (USD billion), by Application, 2025 & 2034
  • Figure 9: North America Blood Transfusion Diagnostics Market Value Share (%), by Application, 2025
  • Figure 10: North America Blood Transfusion Diagnostics Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 11: North America Blood Transfusion Diagnostics Market Value Share (%), by End-user, 2025
  • Figure 12: North America Blood Transfusion Diagnostics Market Value (USD billion), By Country, 2025 & 2034
  • Figure 13: North America Blood Transfusion Diagnostics Market Value Share (%), By Country, 2025
  • Figure 14: Europe Blood Transfusion Diagnostics Market Value (USD billion), by Product, 2025 & 2034
  • Figure 15: Europe Blood Transfusion Diagnostics Market Value Share (%), by Product, 2025
  • Figure 16: Europe Blood Transfusion Diagnostics Market Value (USD billion), by Application, 2025 & 2034
  • Figure 17: Europe Blood Transfusion Diagnostics Market Value Share (%), by Application, 2025
  • Figure 18: Europe Blood Transfusion Diagnostics Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 19: Europe Blood Transfusion Diagnostics Market Value Share (%), by End-user, 2025
  • Figure 20: Europe Blood Transfusion Diagnostics Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 21: Europe Blood Transfusion Diagnostics Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 22: Asia Pacific Blood Transfusion Diagnostics Market Value (USD billion), by Product, 2025 & 2034
  • Figure 23: Asia Pacific Blood Transfusion Diagnostics Market Value Share (%), by Product, 2025
  • Figure 24: Asia Pacific Blood Transfusion Diagnostics Market Value (USD billion), by Application, 2025 & 2034
  • Figure 25: Asia Pacific Blood Transfusion Diagnostics Market Value Share (%), by Application, 2025
  • Figure 26: Asia Pacific Blood Transfusion Diagnostics Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 27: Asia Pacific Blood Transfusion Diagnostics Market Value Share (%), by End-user, 2025
  • Figure 28: Asia Pacific Blood Transfusion Diagnostics Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 29: Asia Pacific Blood Transfusion Diagnostics Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 30: Latin America Blood Transfusion Diagnostics Market Value (USD billion), by Product, 2025 & 2034
  • Figure 31: Latin America Blood Transfusion Diagnostics Market Value Share (%), by Product, 2025
  • Figure 32: Latin America Blood Transfusion Diagnostics Market Value (USD billion), by Application, 2025 & 2034
  • Figure 33: Latin America Blood Transfusion Diagnostics Market Value Share (%), by Application, 2025
  • Figure 34: Latin America Blood Transfusion Diagnostics Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 35: Latin America Blood Transfusion Diagnostics Market Value Share (%), by End-user, 2025
  • Figure 36: Latin America Blood Transfusion Diagnostics Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 37: Latin America Blood Transfusion Diagnostics Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 38: Middle East & Africa Blood Transfusion Diagnostics Market Value (USD billion), by Product, 2025 & 2034
  • Figure 39: Middle East & Africa Blood Transfusion Diagnostics Market Value Share (%), by Product, 2025
  • Figure 40: Middle East & Africa Blood Transfusion Diagnostics Market Value (USD billion), by Application, 2025 & 2034
  • Figure 41: Middle East & Africa Blood Transfusion Diagnostics Market Value Share (%), by Application, 2025
  • Figure 42: Middle East & Africa Blood Transfusion Diagnostics Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 43: Middle East & Africa Blood Transfusion Diagnostics Market Value Share (%), by End-user, 2025
  • Figure 44: Middle East & Africa Blood Transfusion Diagnostics Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 45: Middle East & Africa Blood Transfusion Diagnostics Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 46: Global Blood Transfusion Diagnostics Market Share (%), By Company, 2025